Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 45

Cited In for PubMed (Select 12414302)

1.

A Cohort Pilot Study on HIV-Associated Neuropsychological Impairments in Hemophilia Patients.

Riva S, Cutica I, Krampe C, Reinecke LF, Russell-Edu W, Santoro C, Rocino A, Santagostino E, Rusconi V, Pravettoni G.

Front Hum Neurosci. 2015 Jun 2;9:313. doi: 10.3389/fnhum.2015.00313. eCollection 2015.

2.

Creatine protects against mitochondrial dysfunction associated with HIV-1 Tat-induced neuronal injury.

Stevens PR, Gawryluk JW, Hui L, Chen X, Geiger JD.

Curr HIV Res. 2014;12(6):378-87.

3.

Associations between brain microstructures, metabolites, and cognitive deficits during chronic HIV-1 infection of humanized mice.

Boska MD, Dash PK, Knibbe J, Epstein AA, Akhter SP, Fields N, High R, Makarov E, Bonasera S, Gelbard HA, Poluektova LY, Gendelman HE, Gorantla S.

Mol Neurodegener. 2014 Dec 18;9:58. doi: 10.1186/1750-1326-9-58.

4.

Brain Abnormalities in HIV and Stimulant Users: Interventions and Prevention.

Chang L, Shoptaw S, Normand J.

J Food Drug Anal. 2013 Dec;21(4):S7-S9.

5.

HIV-1, HCV and alcohol in the CNS: potential interactions and effects on neuroinflammation.

Silverstein PS, Kumar S, Kumar A.

Curr HIV Res. 2014;12(4):282-92. Review.

6.

Effects of APOE ε4, age, and HIV on glial metabolites and cognitive deficits.

Chang L, Jiang C, Cunningham E, Buchthal S, Douet V, Andres M, Ernst T.

Neurology. 2014 Jun 17;82(24):2213-22. doi: 10.1212/WNL.0000000000000526. Epub 2014 May 21.

7.

Modeling deficits in attention, inhibition, and flexibility in HAND.

Moran LM, Booze RM, Mactutus CF.

J Neuroimmune Pharmacol. 2014 Sep;9(4):508-21. doi: 10.1007/s11481-014-9539-z. Epub 2014 Apr 25.

PMID:
24764039
8.

Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART.

Harezlak J, Cohen R, Gongvatana A, Taylor M, Buchthal S, Schifitto G, Zhong J, Daar ES, Alger JR, Brown M, Singer EJ, Campbell TB, McMahon D, So YT, Yiannoutsos CT, Navia BA; HIV Neuroimaging Consortium.

J Neurovirol. 2014 Jun;20(3):294-303. doi: 10.1007/s13365-014-0246-6. Epub 2014 Apr 3.

9.

Select neurocognitive impairment in HIV-infected women: associations with HIV viral load, hepatitis C virus, and depression, but not leukocyte telomere length.

Giesbrecht CJ, Thornton AE, Hall-Patch C, Maan EJ, Côté HC, Money DM, Murray M, Pick N.

PLoS One. 2014 Mar 4;9(3):e89556. doi: 10.1371/journal.pone.0089556. eCollection 2014.

10.

Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine.

Henry BL, Geyer MA, Buell MR, Perry W, Young JW, Minassian A; Translational Methamphetamine AIDS Research Center (TMARC) Group.

Behav Pharmacol. 2014 Feb;25(1):12-22. doi: 10.1097/FBP.0000000000000012.

11.

Quantitative MRI Measures in SIV-Infected Macaque Brains.

Zhang X, Li C.

J Clin Cell Immunol. 2013;Suppl 7. pii: 005.

12.

Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain.

Chang L, Munsaka SM, Kraft-Terry S, Ernst T.

J Neuroimmune Pharmacol. 2013 Jun;8(3):576-93. doi: 10.1007/s11481-013-9460-x. Epub 2013 May 12. Review.

13.

Prepulse inhibition in HIV-associated neurocognitive disorders.

Minassian A, Henry BL, Woods SP, Vaida F, Grant I, Geyer MA, Perry W; Translational Methamphetamine AIDS Research Center (TMARC) Group.

J Int Neuropsychol Soc. 2013 Jul;19(6):709-17. doi: 10.1017/S1355617713000301. Epub 2013 Apr 3.

14.

Neuropsychological test performance before and after HIV-1 seroconversion: the Multicenter AIDS Cohort Study.

Vo QT, Cox C, Li X, Jacobson LP, McKaig R, Sacktor N, Selnes OA, Martin E, Becker JT, Miller EN.

J Neurovirol. 2013 Feb;19(1):24-31. doi: 10.1007/s13365-012-0136-8. Epub 2012 Dec 11.

15.

Neuropsychological function and cerebral metabolites in HIV-infected youth.

Nagarajan R, Sarma MK, Thomas MA, Chang L, Natha U, Wright M, Hayes J, Nielsen-Saines K, Michalik DE, Deville J, Church JA, Mason K, Critton-Mastandrea T, Nazarian S, Jing J, Keller MA.

J Neuroimmune Pharmacol. 2012 Dec;7(4):981-90. doi: 10.1007/s11481-012-9407-7. Epub 2012 Oct 13.

16.

2D MR Spectroscopy Combined with Prior-Knowledge Fitting Is Sensitive to HCV-Associated Cerebral Metabolic Abnormalities.

Nagarajan R, Sarma MK, Thames AD, Castellon SA, Hinkin CH, Thomas MA.

Int J Hepatol. 2012;2012:179365. doi: 10.1155/2012/179365. Epub 2012 Jul 12.

17.

Neuroimaging studies of the aging HIV-1-infected brain.

Holt JL, Kraft-Terry SD, Chang L.

J Neurovirol. 2012 Aug;18(4):291-302. doi: 10.1007/s13365-012-0114-1. Epub 2012 Jun 1. Review.

18.

Clinical and cognitive correlates of the proton magnetic resonance spectroscopy measures in chronic schizophrenia.

Szulc A, Galińska-Skok B, Tarasów E, Konarzewska B, Waszkiewicz N, Hykiel R, Walecki J.

Med Sci Monit. 2012 Jun;18(6):CR390-8.

19.

Functional connectivity measured with magnetoencephalography identifies persons with HIV disease.

Becker JT, Bajo R, Fabrizio M, Sudre G, Cuesta P, Aizenstein HJ, Lopez OL, Wolk D, Parkkonen L, Maestu F, Bagic A.

Brain Imaging Behav. 2012 Sep;6(3):366-73. doi: 10.1007/s11682-012-9149-4.

20.

Neurocognitive effects of HIV, hepatitis C, and substance use history.

Devlin KN, Gongvatana A, Clark US, Chasman JD, Westbrook ML, Tashima KT, Navia B, Cohen RA.

J Int Neuropsychol Soc. 2012 Jan;18(1):68-78. doi: 10.1017/S1355617711001408. Epub 2011 Dec 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk